down arrow

Chemo Pharma Lab

Not Rated
  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE320M01019
  • NSEID:
  • BSEID: 506365
INR
124.45
2.4 (1.97%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Chemo Pharma Lab Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'16
No of Months
12
Profit Before Tax
-1.35
Adjustment
-0.49
Changes In working Capital
-0.18
Cash Flow after changes in Working Capital
-2.01
Cash Flow from Operating Activities
-2.09
Cash Flow from Investing Activities
2.15
Cash Flow from Financing Activities
0.00
Net Cash Inflow / Outflow
0.06
Opening Cash & Cash Equivalents
0.38
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
Effect of Foreign Exchange Fluctuations
0.00
Closing Cash & Cash Equivalent
0.44
Compare Cash Flow Results of Chemo Pharma Lab
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-13469787
910.6
-1,34,70,697.00
-1479321.06%
Adjustment
-4867213
845.2
-48,68,058.00
-575965.24%
Changes In working Capital
-1785494
-36.9
-17,85,458.00
-4838637.13%
Cash Flow after changes in Working Capital
-20122494
1718.9
-2,01,24,212.00
-1170761.12%
Cash Flow from Operating Activities
-20915305
1526.5
-2,09,16,831.00
-1370247.72%
Cash Flow from Investing Activities
21523289
-1458.7
2,15,24,747.00
1475611.69%
Cash Flow from Financing Activities
0
-163.5
163.00
100.00%
Net Cash Inflow / Outflow
607984
-95.7
6,08,079.00
635401.99%
Opening Cash & Cash Equivalents
3779853
284.3
37,79,569.00
1329429.72%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
4387837
188.6
43,87,649.00
2326430.75%
Cash Flow - Snapshot (Standalone) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 205.88% vs -106.06% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
0.72
-0.68
205.88%